PGFC
CLPT icon

Peapack-Gladstone Financial Corp’s ClearPoint Neuro CLPT Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,730
Closed -$269K – 639
2021
Q1 		$269K Sell
12,730
-4,000
-24% -$85.6K 0.01% 505
2020
Q4 		$266K Buy
+16,730
New +$150K 0.01% 365

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CCM
Conway Capital Management Burbank, California $214M AUM 22.99% 1-Year Est. Return

Peapack-Gladstone Financial Corp's CLPT Position: Q2 2021 in Review

Peapack-Gladstone Financial Corp sold out of ClearPoint Neuro (CLPT) in Q2 2021, closing a stake of 12,730 shares — an estimated $269K sold.

Peapack-Gladstone Financial Corp first reported a position in CLPT in Q4 2020 and held it in 2 quarters. The position peaked at $269K in Q1 2021. 76 funds tracked by Wall St. Rank hold CLPT as of Q2 2021.

  • Peapack-Gladstone Financial Corp reported no remaining ClearPoint Neuro position as of Q2 2021 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 12,730 ClearPoint Neuro shares in Q2 2021, an estimated $269K.
  • Peapack-Gladstone Financial Corp first reported a position in ClearPoint Neuro in Q4 2020 and held it in 2 quarters.
  • Peapack-Gladstone Financial Corp's ClearPoint Neuro position peaked at $269K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2021.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2021, filed 16 Aug 2021.